Stay updated on Ixekizumab Efficacy in Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the Ixekizumab Efficacy in Psoriatic Arthritis Clinical Trial page.

Latest updates to the Ixekizumab Efficacy in Psoriatic Arthritis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision tag updated to v3.4.3 and the previous v3.4.2 entry removed.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedRevision history updated: added v3.4.2 and removed v3.4.1, reflecting a record-keeping update with no changes to study data or eligibility criteria.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision: v3.4.1 has been added, replacing v3.4.0; this is an internal versioning update with no visible impact on study details or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check53 days agoChange DetectedGlossary visibility controls were added (Show glossary and Hide glossary), and minor wording/capitalization tweaks were made to QC labels and the No FEAR Act reference. The revision was updated to v3.4.0 (replacing v3.3.4).SummaryDifference0.1%

- Check60 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check88 days agoChange DetectedThe study's Locations entries were updated (rev. v3.3.3): new site locations were added across multiple US states (AL, AR, CA, CT, FL, GA, IN, IA, KS, MD, MO, NJ, NY, NC, OH, PA, SC, TN, TX, WA, WV) and international sites (Ontario, Cambridgeshire, Essex, Greater London, Oxford, West Midlands, West Yorkshire), while corresponding entries were removed.SummaryDifference1%

Stay in the know with updates to Ixekizumab Efficacy in Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ixekizumab Efficacy in Psoriatic Arthritis Clinical Trial page.